NO20006699L - Forbindelser med veksthormonfrigjörende egenskaper - Google Patents

Forbindelser med veksthormonfrigjörende egenskaper

Info

Publication number
NO20006699L
NO20006699L NO20006699A NO20006699A NO20006699L NO 20006699 L NO20006699 L NO 20006699L NO 20006699 A NO20006699 A NO 20006699A NO 20006699 A NO20006699 A NO 20006699A NO 20006699 L NO20006699 L NO 20006699L
Authority
NO
Norway
Prior art keywords
growth hormone
compounds
hormone releasing
releasing properties
properties
Prior art date
Application number
NO20006699A
Other languages
English (en)
Other versions
NO20006699D0 (no
NO331351B1 (no
Inventor
Bernd Peschke
Stefan Lutz Richter
Thomas Kruse Hansen
Michael Ankersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO20006699D0 publication Critical patent/NO20006699D0/no
Publication of NO20006699L publication Critical patent/NO20006699L/no
Publication of NO331351B1 publication Critical patent/NO331351B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
NO20006699A 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper NO331351B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199800857 1998-06-30
DKPA199801440 1998-11-09
PCT/DK1999/000368 WO2000001726A1 (en) 1998-06-30 1999-06-29 Compounds with growth hormone releasing properties

Publications (3)

Publication Number Publication Date
NO20006699D0 NO20006699D0 (no) 2000-12-29
NO20006699L true NO20006699L (no) 2001-02-28
NO331351B1 NO331351B1 (no) 2011-12-05

Family

ID=26064788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006699A NO331351B1 (no) 1998-06-30 2000-12-29 Forbindelser med veksthormonfrigjorende egenskaper

Country Status (20)

Country Link
EP (1) EP1100824B1 (no)
JP (1) JP4511040B2 (no)
KR (1) KR100907638B1 (no)
CN (1) CN1304424C (no)
AT (1) ATE500269T1 (no)
AU (1) AU771644B2 (no)
BR (1) BRPI9911756B1 (no)
CA (1) CA2334315C (no)
CY (1) CY1111509T1 (no)
CZ (1) CZ299648B6 (no)
DE (1) DE69943239D1 (no)
DK (1) DK1100824T3 (no)
HU (1) HUP0102460A3 (no)
IL (1) IL140044A0 (no)
NO (1) NO331351B1 (no)
PL (1) PL199853B1 (no)
PT (1) PT1100824E (no)
RU (1) RU2298547C2 (no)
TW (1) TW593337B (no)
WO (1) WO2000001726A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002331064B2 (en) * 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CA2565324A1 (en) * 2004-03-30 2005-10-20 Sapphire Therapeutics, Inc. Method of reducing c-reactive protein using growth hormone secretagogues
WO2006020930A2 (en) 2004-08-12 2006-02-23 Sapphire Therapeutics, Inc. Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
EP1883627B1 (en) * 2005-05-18 2018-04-18 Pharmascience Inc. Bir domain binding compounds
KR20080067357A (ko) 2005-10-25 2008-07-18 에게라 쎄라퓨틱스 인코포레이티드 Ｉａｐ ｂｉｒ 도메인 결합 화합물
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
CN107382827B (zh) * 2017-04-14 2021-01-01 江苏普莱医药生物技术有限公司 氨基酸衍生物或其药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924506A1 (de) * 1989-07-25 1991-01-31 Hoechst Ag Renin-hemmende aminooligohydroxy-derivate
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
EP0833845A1 (en) * 1995-06-22 1998-04-08 Novo Nordisk A/S Compounds with growth hormone releasing properties
HUP9802580A3 (en) * 1995-12-22 1999-03-29 Novo Nordisk As Compounds with growth hormone releasing properties
EP0923539B1 (en) * 1996-07-22 2002-06-05 Novo Nordisk A/S Compounds with growth hormone releasing properties
AU7906998A (en) * 1997-06-20 1999-01-04 Novo Nordisk A/S Compounds with growth hormone releasing properties

Also Published As

Publication number Publication date
CZ20004565A3 (en) 2001-06-13
HUP0102460A3 (en) 2001-12-28
WO2000001726A1 (en) 2000-01-13
IL140044A0 (en) 2002-02-10
NO20006699D0 (no) 2000-12-29
KR100907638B1 (ko) 2009-07-14
EP1100824A1 (en) 2001-05-23
CN1307588A (zh) 2001-08-08
CN1304424C (zh) 2007-03-14
HUP0102460A2 (hu) 2001-11-28
BRPI9911756B1 (pt) 2016-06-14
RU2298547C2 (ru) 2007-05-10
AU771644B2 (en) 2004-04-01
DK1100824T3 (da) 2011-06-20
DE69943239D1 (de) 2011-04-14
BR9911756A (pt) 2001-04-03
NO331351B1 (no) 2011-12-05
CY1111509T1 (el) 2015-08-05
TW593337B (en) 2004-06-21
JP4511040B2 (ja) 2010-07-28
ATE500269T1 (de) 2011-03-15
PL199853B1 (pl) 2008-11-28
KR20010053310A (ko) 2001-06-25
CZ299648B6 (cs) 2008-10-01
JP2002519436A (ja) 2002-07-02
EP1100824B1 (en) 2011-03-02
CA2334315C (en) 2011-07-26
CA2334315A1 (en) 2000-01-13
PT1100824E (pt) 2011-06-16
AU4603899A (en) 2000-01-24
PL345204A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
IL129592A0 (en) 5-HT1f agonists
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
YU13301A (sh) Muskarinski agonisti i antagonisti
SE9802937D0 (sv) Novel compounds
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
TR200200278T2 (tr) Kalsilitik bileşimler
ID25478A (id) Agonis 5-ht1f
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
NO20003629D0 (no) Forbindelser med veksthormonfrigjørende egenskaper
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HELSINN HEALTHCARE SA, CH

MM1K Lapsed by not paying the annual fees